Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney - PubMed (original) (raw)
Comparative Study
. 1998 May 22;273(21):12960-6.
doi: 10.1074/jbc.273.21.12960.
Affiliations
- PMID: 9582329
- DOI: 10.1074/jbc.273.21.12960
Free article
Comparative Study
Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney
T H van Kuppevelt et al. J Biol Chem. 1998.
Free article
Abstract
Detailed analysis of various heparan sulfate (HS) species is seriously hampered by a lack of appropriate tools, such as antibodies. We adopted phage display technology to generate anti-HS antibodies. A "single pot" semisynthetic human antibody phage display library was subjected to four rounds of selection on HS from bovine kidney using panning methodology. Three different phage clones expressing anti-HS single chain variable fragment antibodies (HS4C3, HS4D10, and HS3G8) were isolated, with an amino acid sequence of the complementarity-determining region 3 of GRRLKD (VH3 gene, DP-38), SLRMNGCGAHQ (VH3 gene, DP-42), and YYHYKVN (VH1 gene, DP-8), respectively. The antibodies react with HS and heparin, but not with DNA or other glycosaminoglycans. Kd values for HS are about 0.1 microM. The three antibodies react differently toward various HS preparations and show different staining patterns on rat kidney sections, indicating recognition of different HS molecules. This also holds for two described mouse anti-HS IgMs (JM403 and 10E4; both generated by conventional hybridoma technique) and indicates the presence of at least 5 different HS species in the kidney. O- and N-sulfation are important for binding of HS to HS4C3 and HS3G8. The three single chain antibodies, but not JM403, block a basic fibroblast growth factor binding site of HS. It is concluded that phage display technology presents a powerful technique to generate antibodies specific for HS epitopes. This is the first time this technique has been successfully applied to obtain directly antibodies to (poly)saccharides.
Similar articles
- Construction and evaluation of an antibody phage display library targeting heparan sulfate.
Damen LAA, van de Westerlo EMA, Versteeg EMM, van Wessel T, Daamen WF, van Kuppevelt TH. Damen LAA, et al. Glycoconj J. 2020 Aug;37(4):445-455. doi: 10.1007/s10719-020-09925-z. Epub 2020 May 28. Glycoconj J. 2020. PMID: 32468289 Free PMC article. - Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies.
Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH. Dennissen MA, et al. J Biol Chem. 2002 Mar 29;277(13):10982-6. doi: 10.1074/jbc.M104852200. Epub 2002 Jan 14. J Biol Chem. 2002. PMID: 11790764 - Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.
Jenniskens GJ, Oosterhof A, Brandwijk R, Veerkamp JH, van Kuppevelt TH. Jenniskens GJ, et al. J Neurosci. 2000 Jun 1;20(11):4099-111. doi: 10.1523/JNEUROSCI.20-11-04099.2000. J Neurosci. 2000. PMID: 10818145 Free PMC article. - Use of a phage display antibody to measure the enzymatic activity of the Sulfs.
Uchimura K, Lemjabbar-Alaoui H, van Kuppevelt TH, Rosen SD. Uchimura K, et al. Methods Enzymol. 2010;480:51-64. doi: 10.1016/S0076-6879(10)80003-5. Methods Enzymol. 2010. PMID: 20816204 Review. - Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis?
Berden JH, Termaat RM, Brinkman K, Smeenk RJ, Swaak AJ, Faaber P, Assmann K, van de Heuvel LP, Veerkamp JH. Berden JH, et al. Nephrologie. 1989;10(3):127-32. Nephrologie. 1989. PMID: 2532712 Review.
Cited by
- Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains.
Damen LAA, Bui TP, van Wessel T, Li Y, Straten BF, Pampiermole R, Daamen WF, Fernig DG, van Kuppevelt TH. Damen LAA, et al. Glycobiology. 2024 Jun 22;34(8):cwae046. doi: 10.1093/glycob/cwae046. Glycobiology. 2024. PMID: 38963938 Free PMC article. - A Conditionally Activated Cytosol-Penetrating Antibody for TME-Dependent Intracellular Cargo Delivery.
Dombrowsky CS, Happel D, Habermann J, Hofmann S, Otmi S, Cohen B, Kolmar H. Dombrowsky CS, et al. Antibodies (Basel). 2024 May 2;13(2):37. doi: 10.3390/antib13020037. Antibodies (Basel). 2024. PMID: 38804305 Free PMC article. - Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis.
Maciej-Hulme ML, Van Gemst JJ, Sanderson P, Rops ALWMM, Berden JH, Smeets B, Amster IJ, Rabelink TJ, Van Der Vlag J. Maciej-Hulme ML, et al. Front Mol Biosci. 2023 Jun 1;10:1177560. doi: 10.3389/fmolb.2023.1177560. eCollection 2023. Front Mol Biosci. 2023. PMID: 37325479 Free PMC article. - Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens.
Khilji SK, Op 't Hoog C, Warschkau D, Lühle J, Goerdeler F, Freitag A, Seeberger PH, Moscovitz O. Khilji SK, et al. Theranostics. 2023 May 15;13(9):3041-3063. doi: 10.7150/thno.80901. eCollection 2023. Theranostics. 2023. PMID: 37284439 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous